Leerink Swann initiated coverage on Agios Pharma (NASDAQ: AGIO) with an Outperform rating and a price target of $38.00.

This article: 109 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE